SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-122072
Filing Date
2021-04-20
Accepted
2021-04-20 09:10:55
Documents
12
Period of Report
2021-04-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d106480d8k.htm   iXBRL 8-K 33347
  Complete submission text file 0001193125-21-122072.txt   163543

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gwph-20210420.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20210420_lab.xml EX-101.LAB 18839
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20210420_pre.xml EX-101.PRE 11836
5 EXTRACTED XBRL INSTANCE DOCUMENT d106480d8k_htm.xml XML 3667
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35892 | Film No.: 21836432
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences